NOXXON PHARMA N.V. REPORTS 2017 FINANCIAL RESULTS
Year marked by advance of clinical strategy
Year marked by advance of clinical strategy
First licensing agreement for lead compound lefitolimod concluded | Significant progress in studies | Company funding secured until the end of 2018 through successful capital measures
Charité clinician Regine Heilbronn and her research team convince the Federal Ministry of Education and Research (BMBF) at the GO-Bio Competition, daring to take the leap from the laboratory to medical application. The scientists were chosen for…
Berlin, Germany, April 18th, 2018
The MDC start-up project “Captain T Cell” has been awarded several million Euros from the German Federal Ministry of Education and Research (BMBF) as part of its GO-Bio funding initiative. The aim of the project is to develop new cancer-fighting…
Following approval in the UK in 2017, Humedics has now also received Marketing Authorization for its diagnostic agent, LiMAxetin®, in Germany and Austria.
After five years of follow-up observation, CO.DON AG has brought the Phase II clinical trial “co.dis” to a successful close. In the long-term clinical study 75 patients aged between 18 and 50, with cartilage defects in the knee, were treated with the…
From April 1, 2018 Professor Roland Eils takes up the professorship for Digital Health at the Berlin Institute of Health (BIH) and the Charité – Universitätsmedizin Berlin. Professor Eils will therefore take responsibility for one of the central…
Background
Sensors with the features: portable, low-power, label-free, real-time, compact, high sensitivity, high-throughput, and cost-effective are highly attractive because they can be used in a wide range of fields such as environmental…